Health advice and immunizations for travelers

New England Journal of Medicine

Volumn 342, Issue 23, 2000, Pages 1716-1725

  Ryan, Edward T ^a   Kain, Kevin C ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; BCG VACCINE; CHLOROQUINE; CIPROFLOXACIN; DIPLOID CELL VACCINE; HEPATITIS A VACCINE; IMMUNOGLOBULIN; LEVOFLOXACIN; LIVE VACCINE; LOPERAMIDE; MEFLOQUINE; NORFLOXACIN; OFLOXACIN; PRIMAQUINE; PROGUANIL; RABIES VACCINE; RECOMBINANT HEPATITIS B VACCINE; SALMONELLOSIS VACCINE; TYPHOID VACCINE; VIRUS VACCINE;

IMMUNIZATION; INFECTION RISK; MALARIA; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; TRAVEL; TRAVELLER DIARRHEA;

ALTITUDE SICKNESS; DIARRHEA; HUMANS; IMMUNIZATION; INTERNET; MALARIA; PREVENTIVE MEDICINE; RISK ASSESSMENT; SEXUALLY TRANSMITTED DISEASES; TRAVEL;

EID: 0034622083     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200006083422306     Document Type: Review

References (67)

1. The state of world health. In: The world health report 1996 - fighting disease, fostering development. Geneva: World Health Organization, 1997: 1-62.
2. Kozarsky PE. Prevention of common travel ailments. Infect Dis Clin North Am 1998;12:305-24.
3. Steffen R, Rickenbach M, Wilhelm U, Helminger A, Schar M. Health problems after travel to developing countries. J Infect Dis 1987;156:84-91.
4. Steffen R, Jong EC. Travelers' and immigrants' health. In: Guerrant RL, Walker DH, Wyler PF, eds. Tropical infectious diseases: principles, pathogens and practice. Philadelphia: Churchill Livingstone, 1999:106-14.
5. Reid D, Keystone JS. Health risks abroad: general considerations. In: DuPont HL, Steffen R, eds. Textbook of travel medicine and health. Hamilton, Ont.: B.C. Decker, 1997:3-9.
6. Hargarten SW, Baker TD, Guptill K. Overseas fatalities of United States citizen travelers: an analysis of deaths related to international travel. Ann Emerg Med 1991;20:622-6.
7. Mileno MD, Bia FJ. The compromised traveler. Infect Dis Clin North Am 1998;12:369-412.
8. Health information for international travel 1999-2000. Atlanta: Centers for Disease Control and Prevention, 1999.
9. Steffen R, van der Linde F, Gyr K, Schar M. Epidemiology of diarrhea in travelers. JAMA 1983;249:1176-80.
10. Ericsson CD. Travelers' diarrhea: epidemiology, prevention, and self-treatment. Infect Dis Clin North Am 1998;12:285-303.
11. Ansdell VE, Ericsson CD. Prevention and empiric treatment of traveler's diarrhea. Med Clin North Am 1999;83:945-73.
12. Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobactsr jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333: 1374-9.
13. Taylor DN, Connor BA, Shlim DR. Chronic diarrhea in the returned traveler. Med Clin North Am 1999;83:1033-52.
14. DuPont HL, Ericsson CD. Prevention and treatment of traveler's diarrhea. N Engl J Med 1993;328:1821-7.
15. Advice for travelers. Med Lett Drugs Ther 1999;41:39-42.
16. Smith KE, Besser JM, Hedberg CW, et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J Med 1999; 340:1525-32.
17. Fischer PR. Travel with infants and children. Infect Dis Clin North Am 1998;12:355-68.
18. Neumann K, Behrens RH. Traveling with children. In: DuPont HL, Steffen R, eds. Textbook of travel medicine and health. Hamilton, Ont.: B.C. Decker, 1997:304-10.
19. Samuel BU, Barry M. The pregnant traveler. Infect Dis Clin North Am 1998;12:325-54.
20. Khan WA, Seas C, Dhar U, Salam MA, Bennish ML. Treatment of shigellosis. V. Comparison of azithromycin and ciprofloxacin: a double-blind, randomized, controlled trial. Ann Intern Med 1997;126:697-703.
21. Shanks GD, Smoak BL, Aleman GM, et al. Single dose of azithromycin or three-day course of ciprofloxacin as therapy for epidemic dysentery in Kenya. Clin Infect Dis 1999;29:942-3.
22. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(RR-8):1-24.
23. Rigau-Perez JG, Gubler DJ, Vorndam AV, Clark GG. Dengue: a literature review and case study of travelers from the United States, 1986-1994. J Travel Med 1997;4:65-71.
24. Fradin MS. Mosquitoes and mosquito repellents: a clinician's guide. Ann Intern Med 1998;128:931-40.
25. Lobel HO, Kozarsky PE. Update on prevention of malaria for travelers. JAMA 1997;278:1767-71.
26. Kain KC, Keystone JS. Malaria in travelers: epidemiology, disease, and prevention. Infect Dis Clin North Am 1998;12:267-84.
27. Wyler DJ. Malaria chemoprophylaxis for the traveler. N Engl J Med 1993;329:31-7.
28. International travel and health: vaccination requirements and health advice. Geneva: World Health Organization, 1999.
29. Ohrt C, Richie TL, Widjaja H, et al. Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997;126: 963-72.
30. Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Lancet 1993;341:1299-303.
31. Hill DR, Behrens RH, Bradley DJ. The risk of malaria in travellers to Thailand. Trans R Soc Trop Med Hyg 1996;90:680-1.
32. Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993; 341:848-51.
33. Croft A, Garner P. Mefloquinc to prevent malaria: a systematic review of trials. BMJ 1997;315:1412-6.
34. Weinke T, Trautmann M, Held T, et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 1991;45:86-91.
35. Barrett PJ, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. BMJ 1996;313:525-8.
36. Fryauff DJ, Baird JK, Basri H, et al. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet 1995;346:1190-3.
37. Soto J, Toledo J, Rodriquez M, et al. Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998; 129:241-4.
38. Prevention of malaria. Med Lett 2000;42:8-9.
39. Brueckner RP, Lasseter KC, Lin ET, Schuster BG. First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. Am J Trop Med Hyg 1998;58:645-9.
40. Shanks GD, Kremsner PG, Sukwa TY, et al. Atovaquone and proguanil hydrochloride for prophylaxis of malaria. J Travel Med 1999;6:Suppl 1: S21-S27.
41. Mulhall BP. Sexually transmissible diseases and travel. Br Med Bull 1993;49:394-411.
42. Stricker M, Steffen R, Hornung R, Gutzwiller F, Eichmann A, Witassek F. Flüchtige sexuelle Kontakte von Schweizer Touristen in den Tropen. Muench Med Wochenschr 1990;132:175-7.
43. Houweling H, Coutinho RA. Risk of HIV infection among Dutch expatriates in sub-Saharan Africa. Im J STD AIDS 1991;2:252-7.
44. Honigman B, Theis MK, Koziol-McLain J, et al. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med 1993;118:587-92. [Erratum, Ann Intern Med 1994;120:698.]
45. Reid LD, Carter KA, Ellsworth A. Acetazolamide or dexamethasone for prevention of acute mountain sickness: a meta-analysis. J Wilderness Med 1994;5:34-8.
46. Bärtsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med 1991; 325:1284-9.
47. Auerbach PS. Marine envenomations. N Engl J Med 1991;325:486-93.
48. DuPont HL, Valk TH, Heltberg J. Psychiatric illness and stress. In: DuPont HL, Steffen R, eds. Textbook of travel medicine and health. Hamilton, Ont.: B.C. Decker, 1997:253-7.
49. Closek MA, DuPont HL. Bites and stings. In: DuPont HL, Steffen R, eds. Textbook of travel medicine and health. Hamilton, Ont.: B.C. Decker, 1997:261-4.
50. Jong EC. Travel immunizations. Med Clin North Am 1999;83:903-22.
51. Recommended childhood immunization schedule - United States, 2000. MMWR Morb Mortal Wkly Rep 2000;49:35-47.
52. Update: recommendations to prevent hepatitis B virus transmission -United States. MMWR Morb Mortal Wkly Rep 1999;48:33-4.
53. Yellow fever vaccine: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1990; 39(RR-6):1-15.
54. Steffen R, Kane MA, Shapiro CN, Billo N, Schoellhorn KJ, van Damme P. Epidemiology and prevention of hepatitis A in travelers. JAMA 1994;272:885-9.
55. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999;48(RR-12):1-37
56. Thoelen S, Van Damme P, Leentvaar-Kuypers A, et al. The first combined vaccine against hepatitis A and B: an overview. Vaccine 1999;17: 1657-62.
57. Typhoid immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1994;43(RR-14):1-7.
58. Wittlinger F, Steffen R, Watanabe H, Handszuh H. Risk of cholera among Western and Japanese travelers. J Travel Med 1995;2:154-8.
59. Ryan ET, Calderwood SB. Cholera vaccines. Clin Infect Dis (in press).
60. Parviz S, Luby S, Wilde H. Postexposure treatment of rabies in Pakistan. Clin Infect Dis 1998;27:751-6.
61. Human rabies prevention - United States, 1999: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999;48(RR-1):1-21. [Erratum, MMWR Morb Mortal Wkly Rep 1999;48:16.]
62. Plotkin SA. Rabies. Clin Infect Dis 2000;30:4-12.
63. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(RR-5):1-10.
64. Inactivated Japanese encephalitis virus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1993;42(RR-1):1-15.
65. The role of BCG vaccine in the prevention and control of tuberculosis in the United States: a joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 1996;45(RR-4):1-18.
66. Thanassi WT, Schoen RT. The Lyme disease vaccine: conception, development, and implementation. Ann Intern Med 2000;132:661-8.
67. Dumpis U, Crook D, Oksi J. Tick-borne encephalitis. Clin Infect Dis 1999;28:882-90.